VELDURIV
Live / Applied — Examiner's amendment mailed (as of 26 Oct 2026)
What this means for you
Not registered yet, but its 24 Sept 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50127690
- Mark type
- Word mark
- Filed
- 24 Sept 2026
- Attorney of record
- Brent A. Johnson
Goods and services
- Class 005 — Pharmaceuticals: Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, cataplexy in narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, diabetes, hypertension, skin disorders, allergies, asthma, obesity, hair loss, epilepsy and tourette's schizophrenia
Owner
- Axsome Therapeutics, Inc., New York, NY, US
Prosecution history
- 26 Oct 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 26 Oct 2026 — EXAMINER'S AMENDMENT ENTERED
- 26 Oct 2026 — EXAMINERS AMENDMENT E-MAILED
- 26 Oct 2026 — EXAMINERS AMENDMENT -WRITTEN
- 04 Oct 2026 — ASSIGNED TO EXAMINER
- 24 Sept 2026 — APPLICATION FILING RECEIPT MAILED
- 24 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Sept 2026 — NEW APPLICATION ENTERED